All News #Library
Others
Wavelength Further Strengthens Its Global Supply Chain Acquisition of Vanamali
17 Feb 2021 //
BUSINESSWIRE
HPAPI Complexity Prompts New Delivery Mechanisms
03 Dec 2020 //
PHARMTECH
Production Scale Up to Meet COVID-19 Demand
09 Sep 2020 //
CONTRACT PHARMA
Ensuring a Safe and Robust Supply of Pharma Materials
03 Aug 2020 //
PHARMTECH
Wavelength Pharmaceuticals Expands Supplies of Key Drug Ingredients for Critically Ill COVID-19 Patients
20 Apr 2020 //
PRESS RELEASE
Wavelength Expands Supplies of Key Drug Ingredients for Critically Ill COVID-19
20 Apr 2020 //
BIOSPACE
Wavelength’s Cetirizine Dihydrochloride confirmed to be free of nitrosamine
19 Apr 2020 //
PRESS RELEASE
Wavelength’s Cilostazol confirmed to be free of nitrosamine impurities
18 Apr 2020 //
PRESS RELEASE
Wavelength Resolves a Majo CASE STUDY Supply Crisis for a Leading API Mfg
17 Apr 2020 //
PRESS RELEASE
Wavelength Pharmaceuticals Resolves a Major Supply Crisis for a Leading API MFG
17 Apr 2020 //
PRESS RELEASE
Wavelength Resolves a Major CASE STUDY Supply Crisis for a API Manufacturer
04 Apr 2020 //
PRESS RELEASE
Wavelength will be exhibiting at Contract Pharma’s 2020 Contracting
05 Feb 2020 //
PRESS RELEASE
Wavelength Pharmaceuticals Obtained on March 28th 2019 CEP For Fulvestrant
15 Apr 2019 //
PRESS RELEASE
Wavelength Pharmaceuticals Obtained on March 28th 2019 CEP For Fulvestrant
12 Mar 2019 //
PRESS RELEASE
Israeli Pharma Company Wavelength Appoints New CEO
30 Nov 2017 //
CALCALISTECH
Wavelength `S Names Iftach Seri as Chief Executive Officer and Tami Cohen as CFO
17 Nov 2017 //
BUSINESSWIRE
SK Capital will pay $110m for Perrigo`s drug ingredients business
15 Aug 2017 //
IN PHARMATECHNOLOGIST
SK Capital To Buy Perrigo`s Active Pharma Ingredients Business
10 Aug 2017 //
NASDAQ

Market Place
Sourcing Support